Cord blood stem cells CD133+ for heart applications

New research has found that stem cells derived from human cord blood could be an effective alternative in repairing heart attacks.

The study, funded by the British Heart Foundation (BHF) and the National Institute for Health Research (NIHR), found that it is possible to expand up to seven-fold, in vitro, rare stem cells (called CD133+) from human cord blood and then grow them into cardiac muscle cells.

Read the full article on bristol.ac.uk